Wed, 23 Aug 2017 15:35:20: No need for 60%-plus discounts on Repatha, Amgen says, rolling out real-world data as backup

Wed, 23 Aug 2017 14:04:37: With IBD market set for major growth, AbbVie stands to benefit: analyst

Wed, 23 Aug 2017 12:57:23: Digital-minded Novartis taps Apple's ResearchKit for smartphone MS study

Wed, 23 Aug 2017 11:17:51: Ironwood zeroes in on primary care doctors with new gout combo med Duzallo

Tue, 22 Aug 2017 23:58:00: Pfizer's Eucrisa beats Dupixent to the DTC punch in eczema, thanks to first-to-market status

Tue, 22 Aug 2017 19:06:17: Flu season early bird Seqirus debuts Fluad TV ad campaign targeting seniors

Tue, 22 Aug 2017 15:30:50: Bidders line up for Teva's women's health unit in potential $2B sale

Tue, 22 Aug 2017 15:24:37: No big growth in 10 years for Big Pharma's workforce, but lots of restructuring

Tue, 22 Aug 2017 14:16:20: Shire CFO, along with analysts, tries to placate investors after surprise exit news sent shares south

Mon, 21 Aug 2017 15:58:48: Ironwood's gout franchise gets a lift with Duzallo combo approval

Mon, 21 Aug 2017 12:42:45: Novartis CEO opens door to cancer patient demanding ‘fair’ CAR-T pricing

Sun, 20 Aug 2017 22:03:54: Siri? Alexa? The doctor will see you now: As hands-free tech use grows, pharma has an opportunity

Sun, 20 Aug 2017 19:51:02: Sanofi shakes up agency team, adding WPP Group to media and creative partners

Fri, 18 Aug 2017 15:04:20: Thank you, Ken Frazier, for a mission impossible: Making pharma look good

Fri, 18 Aug 2017 13:07:55: FiercePharmaAsia—Zai Lab’s $115M IPO, Takeda-Stanford R&D deal, Chinese firms’ bids for Arbor

Fri, 18 Aug 2017 11:04:57: AstraZeneca's Lynparza, armed with new FDA nod, aims to regain share from Tesaro's Zejula

Thu, 17 Aug 2017 19:43:34: Lawmakers dig into 'skyrocketing' MS costs with probe into 7 drugmakers

Thu, 17 Aug 2017 18:45:58: Sanofi tip ends in $465M settlement between Mylan and DOJ

Thu, 17 Aug 2017 15:21:02: Novo Nordisk's new semaglutide trounces Lilly's scrappy Trulicity in diabetes trial

Thu, 17 Aug 2017 14:29:47: Valeant denies bypassing eye-device maker Iconlabs in M&A bid for lens tech

Wed, 16 Aug 2017 20:51:08: Dr. Reddy's revives ex-Novartis OTC brands with slate of new ad campaigns

Wed, 16 Aug 2017 15:33:02: Bristol-Myers puts up Opdivo-plus-Yervoy data, adding to combo-therapy mystery

Wed, 16 Aug 2017 15:04:45: Biocon pulls EU Herceptin biosim app but expects to return to the race next quarter

Wed, 16 Aug 2017 12:17:13: Johnson & Johnson CEO Alex Gorsky leaves Trump council as president breaks it up

Tue, 15 Aug 2017 21:54:20: Surprise: A short list of TV-ad drug risks is easier to recall, FDA study finds